Cancer-Specific Mortality and Competing Mortality in Patients with Head and Neck Squamous Cell Carcinoma: A Competing Risk Analysis

Annals of Surgical Oncology

Volumn 22, Issue 1, 2015, Pages 264-271

  Shen, Weidong ^a   Sakamoto, Naoko ^b   Yang, Limin ^c  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b JUNTENDO UNIVERSITY   (Japan)

^c NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CANCER GRADING; CANCER REGISTRY; CANCER STAGING; CARCINOMA, SQUAMOUS CELL; CAUSE OF DEATH; COMORBIDITY; COMPARATIVE STUDY; FEMALE; FOLLOW UP; HEAD AND NECK NEOPLASMS; HUMAN; MALE; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; NOMOGRAM; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; SURVIVAL RATE; UNITED STATES;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CAUSE OF DEATH; COMBINED MODALITY THERAPY; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NEOPLASM STAGING; NOMOGRAMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; SEER PROGRAM; SURVIVAL RATE; UNITED STATES;

EID: 84939876540     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-014-3951-8     Document Type: Article

References (34)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–917.
2. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA: Cancer J Clin. 2013;63(1):11–30.
3. Kuperman DI, Auethavekiat V, Adkins DR, et al. Squamous cell cancer of the head and neck with distant metastasis at presentation. Head Neck. 2011;33(5):714–8.
4. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 9 Regs Research Data, Nov 2011 Sub (1973-2010) - Linked To County Attributes - Total U.S., 1969–2010 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2013, based on the November 2012 submission.
5. Argiris A, Brockstein BE, Haraf DJ, et al. Competing causes of death and second primary tumors in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapy. Clin Cancer Res. 2004;10(6):1956–62.
6. Adelstein DJ, Li Y, Adams GL, et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol. 2003;21(1):92–8.
7. Mell LK, Dignam JJ, Salama JK, et al. Predictors of competing mortality in advanced head and neck cancer. J Clin Oncol. 2010;28(1):15–20.
8. Gray RJ. A class of k-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1988;16:1141–54.
9. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of competing risks in survival analysis. J Am Stat Assoc. 1999;94:496–509.
10. Harrell FE. Regression modeling strategies: With applications to linear models, logistic regression, and survival analysis. New York: Springer; 2001.
11. Kattan MW, Heller G, Brennan MF. A competing-risks nomogram for sarcoma-specific death following local recurrence. Stat Med. 2003;22(22):3515–25.
12. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. Hoboken, New Jersey: Wiley & Sons, Inc.; 1980.
13. R Core Team (2013). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL http://www.R-project.org/.
14. Frank E Harrell Jr < f.harrell@vanderbilt.edu > (2011). rms: Regression modeling strategies. R package version 3.3-1. http://CRAN.R-project.org/package=rms.
15. Bob Gray < gray@jimmy.harvard.edu > (2011). cmprsk: Subdistribution analysis of competing risks. R package version 2.2-2. http://CRAN.R-project.org/package=cmprsk.
16. Wolbers M, Koller MT, Witteman JC, Steyerberg EW. Prognostic models with competing risks: methods and application to coronary risk prediction. Epidemiology. 2009;20(4):555–61.
17. Pintilie M. Competing risks: a practical perspective. Chichester, West Sussex, England: John Wiley & Sons Ltd.; 2006.
18. Hinchliffe SR, Lambert PC. Flexible parametric modelling of cause-specific hazards to estimate cumulative incidence functions. BMC Med Res Methodol. 2013;13:13.
19. Yang L, Shen W, Sakamoto N. Population-based study evaluating and predicting the probability of death resulting from thyroid cancer and other causes among patients with thyroid cancer. J Clin Oncol. 2013;31(4):468–74.
20. Rose BS, Jeong JH, Nath SK, Lu SM, Mell LK. Population-based study of competing mortality in head and neck cancer. J Clin Oncol. 2011;29(26):3503–9.
21. Iasonos A, Schrag D, Raj GV, Panageas KS. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol. 2008;26(8):1364–70.
22. Hanrahan EO, Gonzalez-Angulo AM, Giordano SH, et al. Overall survival and cause-specific mortality of patients with stage T1a,bN0M0 breast carcinoma. J Clin Oncol. 2007;25(31):4952–60.
23. Porter CR, Suardi N, Capitanio U, et al. A nomogram predicting prostate cancer-specific mortality after radical prostatectomy. Urol Int. 2010;84(2):132–40.
24. Stephenson AJ, Kattan MW, Eastham JA, et al. Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era. J Clin Oncol. 2009;27(26):4300–5.
25. Kutikov A, Egleston BL, Wong YN, Uzzo RG. Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram. J Clin Oncol. Jan 10 2010;28(2):311–7.
26. Pathak KA, Mazurat A, Lambert P, Klonisch T, Nason RW. Prognostic nomograms to predict oncological outcome of thyroid cancers. J Clin Endocrinol Metab. 2013;98(12):4768–75.
27. Kutikov A, Cooperberg MR, Paciorek AT, Uzzo RG, Carroll PR, Boorjian SA. Evaluating prostate cancer mortality and competing risks of death in patients with localized prostate cancer using a comprehensive nomogram. Prostate Cancer Prostatic Dis. 2012;15(4):374–9.
28. Montero PH, Yu C, Palmer FL, et al. Nomograms for preoperative prediction of prognosis in patients with oral cavity squamous cell carcinoma. Cancer. 2014;120(2):214–21.
29. Ali S, Palmer FL, Yu C, et al. Postoperative nomograms predictive of survival after surgical management of malignant tumors of the major salivary glands. Ann Surg Oncol. 2014;21(2):637–42.
30. Du XL, Fox EE, Lai D. Competing causes of death for women with breast cancer and change over time from 1975 to 2003. Am J Clin Oncol. 2008;31(2):105–16.
31. Kircher T, Nelson J, Burdo H. The autopsy as a measure of accuracy of the death certificate. N Engl J Med. 1985;313(20):1263–9.
32. Lughezzani G, Sun M, Shariat SF, et al. A population-based competing-risks analysis of the survival of patients treated with radical cystectomy for bladder cancer. Cancer. 2011;117(1):103–9.
33. Beyersmann J, Schumacher M, Allignol A. Competing risks and multistate Models with R (Use R!). New York, NY: Springer Science + Business Media; 2012.
34. Steyerberg EW. Clinical prediction models: a practical approach to development, validation, and updating. New York: Springer; 2009.